Intention to seek cancellation from trading on AIM

27 July 2016

MediLink-Global UK Limited

("MediLink" or "the Company")

Intention to seek cancellation from trading on AIM

The Board of MediLink announces that it has decided to seek shareholder approval for the cancellation of the Company's ordinary shares from trading on AIM ("Cancellation"). The Directors consider that the costs associated with having its shares admitted to trading on AIM ("Admission") are not commensurate with the associated benefits of Admission.

The Company intends to convene a general meeting shortly, at which it will propose a resolution to approve the Cancellation in accordance with Rule 41 of the AIM Rules for Companies. For Cancellation to become effective, the Company will require not less than 75% of the votes cast by shareholders on the resolution to be in favour of approving the cancellation at the general meeting. A circular setting out, inter alia, further details of the rationale for seeking Cancellation, as well as proposed arrangements for trading in the Company's ordinary shares post cancellation, along with a notice of general meeting, will be prepared by the Company and posted to shareholders in due course.

The information contained within this announcement is deemed by the Directors of the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").

Further announcements will be made as appropriate.

Enquiries: